These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9105959)

  • 1. Predicting outcome of lithium added to antidepressants in resistant depression.
    Alvarez E; Pérez-Solá V; Pérez-Blanco J; Queraltó JM; Torrubia R; Noguera R
    J Affect Disord; 1997 Feb; 42(2-3):179-86. PubMed ID: 9105959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
    Dorevitch A; Ginath Y
    Harefuah; 1991 Dec; 121(11):429-30. PubMed ID: 1786889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment failure with a tricyclic antidepressant followed by lithium addition and response to subsequent electroconvulsive therapy.
    Heijnen WT; van den Broek WW; Birkenhäger TK
    J Clin Psychiatry; 2008 Dec; 69(12):1887-91. PubMed ID: 19014754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.
    Bloch M; Schwartzman Y; Bonne O; Lerer B
    J Clin Psychopharmacol; 1997 Feb; 17(1):44-8. PubMed ID: 9004056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium augmentation in geriatric depression.
    van Marwijk HW; Bekker FM; Nolen WA; Jansen PA; van Nieuwkerk JF; Hop WC
    J Affect Disord; 1990 Dec; 20(4):217-23. PubMed ID: 2149727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.
    Cowen PJ; McCance SL; Ware CJ; Cohen PR; Chalmers JS; Julier DL
    Br J Psychiatry; 1991 Sep; 159():341-6. PubMed ID: 1659918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of adolescents with major depression: implications of the DST and the melancholic clinical subtype.
    Robbins DR; Alessi NE; Colfer MV
    J Affect Disord; 1989; 17(2):99-104. PubMed ID: 2527896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood response to methylphenidate and the Dexamethasone Suppression Test as predictors of treatment response to zimelidine and lithium in major depression.
    Joyce PR
    Biol Psychiatry; 1985 Jun; 20(6):598-604. PubMed ID: 3158354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
    de Montigny C; Cournoyer G; Morissette R; Langlois R; Caillé G
    Arch Gen Psychiatry; 1983 Dec; 40(12):1327-34. PubMed ID: 6418109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loading dose imipramine--new approach to pharmacotherapy of melancholic depression.
    Malhotra S; Santosh PJ
    J Psychiatr Res; 1996; 30(1):51-8. PubMed ID: 8736467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression.
    Bschor T; Adli M; Baethge C; Eichmann U; Ising M; Uhr M; Modell S; Künzel H; Müller-Oerlinghausen B; Bauer M
    Neuropsychopharmacology; 2002 Sep; 27(3):470-8. PubMed ID: 12225704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine-imipramine interaction.
    Leroi I; Walentynowicz MA
    Can J Psychiatry; 1996 Jun; 41(5):318-9. PubMed ID: 8793156
    [No Abstract]   [Full Text] [Related]  

  • 16. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
    Katona CL; Abou-Saleh MT; Harrison DA; Nairac BA; Edwards DR; Lock T; Burns RA; Robertson MM
    Br J Psychiatry; 1995 Jan; 166(1):80-6. PubMed ID: 7894881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy.
    Lauritzen L; Odgaard K; Clemmesen L; Lunde M; Ohrström J; Black C; Bech P
    Acta Psychiatr Scand; 1996 Oct; 94(4):241-51. PubMed ID: 8911559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy refractory depression].
    Hatzinger M; Holsboer-Trachsler E
    Wien Med Wochenschr; 1999; 149(18):511-4. PubMed ID: 10637955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT; Singer W; Levitt AJ; MacDonald C
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.